5 Key Takeaways
-
1
The ophthalmic ASC landscape appears promising as we approach 2026, with solid growth and increased cataract surgical fee reimbursement.
-
2
The ASC patient experience remains highly rated, indicating strong satisfaction among patients undergoing ophthalmic procedures.
-
3
Challenges such as rising operational costs and staffing shortages may impact the financial health of ASCs in the coming year.
-
4
The potential growth of office-based surgery could pose competitive risks for lesser-known ASCs in the ophthalmic field.
-
5
OOSS and The Ophthalmic ASC will continue to advocate for ASCs, ensuring they remain informed and supported amid upcoming challenges.
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.







